Optimal medical treatment of
Angina: How to translate new
evidence into clinical practice?
Angina: How to translate new
evidence into clinical practice?
Speakers
Rasha Al-Lamee (UK)
Evolving management of stable coronary disease: How the revascularization trials are affecting clinical practice
Gabriele Fragasso (Italy)
Comprehensive medical management of ischemic heart disease: From hemodynamic to cellular metabolic mechanisms
Burden of disease & best practices regarding diagnosis
of symptoms
of symptoms
ANGINA: BURDEN OF THE DISEASE
& EVIDENCE-BASED DIAGNOSIS
APPROACHES (PART 3)
& EVIDENCE-BASED DIAGNOSIS
APPROACHES (PART 3)
Optimal medical treatment of Angina:
How to translate new evidence
into clinical practice?
Speakers
Rasha Al-Lamee (UK)
Evolving management of stable coronary disease: How the revascularization trials are affecting clinical practice
Gabriele Fragasso (Italy)
Comprehensive medical management of ischemic heart disease: From hemodynamic to cellular metabolic mechanisms
Home>Webinars
ANGINA: BURDEN OF THE
DISEASE & EVIDENCE-BASED DIAGNOSIS APPROACHES (PART 3)
Burden of disease & best practices regarding diagnosis
of symptoms
F. Pinto
ANGINA: BURDEN OF THE DISEASE & EVIDENCE-BASED DIAGNOSIS APPROACHES (PART 3)
Burden of disease & best practices regarding diagnosis of symptoms
F. Pinto
EXPERT OF THE MONTH
8 December 2021
Juan Carlos Kaski (UK)
Juan-Carlos Kaski is Emeritus Professor of Cardiovascular Science and the immediate past-director of the Cardiovascular and Cell Sciences Research Institute at St George’s, University of London, UK. His...
IN THE LITERATURE THIS WEEK
Angina resolution and percutaneous coronary intervention: a review
by Z. Beketova 25 January 2023Percutaneous coronary intervention, PCI, aims to relieve angina symptoms in patients with stable coronary artery disease. However, predicting symptom resolution post-percutaneous coronary intervention….
Latest featured publications
Angina
Angina resolution and percutaneous coronary intervention: a review
by Z. Beketova 25 January 2023Percutaneous coronary intervention, PCI, aims to relieve angina symptoms in patients with stable coronary artery disease. However, predicting symptom resolution post-percutaneous coronary intervention has proven difficult as the predictors are ill-defined. Furthermore, there is little evidence which supports the fact that...
Angina
Percutaneous coronary intervention: a review
by Z. Beketova 25 January 2023Many studies have explored percutaneous coronary intervention, PCI, in patients with coronary artery disease to understand whether cardiovascular events and angina are relieved by PCI. In the trials COURAGE and ISCHEMIA, it was found that revascularization did not reduce cardiovascular events,...
Angina
Ischemia and no obstructive coronary arteries: a review
by Z. Beketova 23 January 2023Ischaemia with no obstructive coronary arteries, INOCA, is a condition which contributes to cardiovascular mortality, myocardial infarction and heart failure. This condition is more common in women, and often leads to recurrent hospitalisations and a lower quality of life. Underlying factors...
Angina
Non-obstructive plaque and INOCA treatments: a review
by Z. Beketova 23 January 2023Ischaemia with no obstructive coronary arteries, INOCA, can be defined by the following criteria: (1) stable, long-lasting symptoms that include angina, (2) evidence of myocardial ischemia through ECG or cardiac imaging, both at rest or during physical/mental stress, and (3) an...
Angina
Angina after PCI in Focal and Diffuse Coronary Artery Disease: a review
by Z. Beketova 17 January 2023After percutaneous coronary intervention, an increase in fractional flow reserve often correlates with patients experiencing improvements in angina. However, focal and diffuse coronary artery disease patterns influence the change in fractional flow reserve, which may influence angina improvement. 103 patients were...
Latest Videos
Heart failure
1 September 2022HF management in real-world clinical practice (s.2-p.7)
Heart faliure
1 September 2022HF management in real-world clinical practice (s.2-p.6)
Heart faliure
1 September 2022HF management in real-world clinical practice (s.2-p.5)
Heart faliure
1 September 2022HF management in real-world clinical practice (s.2-p.4)
Heart faliure
1 September 2022HF management in real-world clinical practice (s.2 –…
Heart faliure
1 September 2022HF management in real-world clinical practice (s.2 –…
upcoming Webinar
No upcoming webinar
Latest pubmed articles
- Angina Pectoris and the Importance of Coronary Microcirculation in Practice
- Reassured on a background of vulnerability - people with microvascular angina 12 months after high-intensity physical exercise program
- Updates on Pharmacologic Management of Microvascular Angina
- Beyond Coronary Artery Disease: Assessing the Microcirculation
- Prognostic association of plasma NT-proBNP levels in patients with microvascular angina -A report from the international cohort study by COVADIS
- Exploring the mechanism of Shexiang Tongxin dropping pill in the treatment of microvascular angina through network pharmacology and molecular docking
- Refractory microvascular angina in hypertrophic cardiomyopathy: a novel therapy?
- Predictive value of lymphocyte to monocyte ratio for cardiac syndrome X
- Coronary microvascular dysfunction: mechanisms and clinical outcome
- Phenotype-based management of coronary microvascular dysfunction
- The Central Nervous System and Psychosocial Factors in Primary Microvascular Angina
- Definition and epidemiology of coronary microvascular disease
- Coronary Microvascular Angina: A State-of-the-Art Review
- Systemic Immune-Inflammation Index as a Predictor of Microvascular Dysfunction in Patients With Cardiac Syndrome X
- Interventional Diagnostic Procedure: a Practical Guide for the Assessment of Coronary Vascular Function
Become a member
Stay up-to-date with the latest educational material, events and more on Angina and Heart Failure through us by becoming a member today.